FMO5 and Parkinson disease: In conclusion, TSPO knockdown and its ligand PK11195 could attenuate neuronal dopaminergic damage in an MPTP acute PD model, attenuate NADPH oxidase activity, and increase M2 inflammatory factors via P47.